Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037482

Chief Legal Officer sold 45,119 shares at an average $22.10 ($996,963)

  • Chief Legal Officer acquired 33,189 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2021-06-01 Option exercise +33,189 176,807 D
Ali-Jackson Kamil Chief Legal Officer 2021-06-01 Sale −9,746 $22.72 $221,448 167,061 D
Ali-Jackson Kamil Chief Legal Officer 2021-06-01 Sale −5,254 $23.57 $123,851 161,807 D
Ali-Jackson Kamil Chief Legal Officer 2021-06-02 Sale −12,483 $21.50 $268,412 149,324 D
Ali-Jackson Kamil Chief Legal Officer 2021-06-02 Sale −2,517 $22.32 $56,173 146,807 D
Ali-Jackson Kamil Chief Legal Officer 2021-06-02 Sale −12,732 $21.51 $273,822 134,075 D
Ali-Jackson Kamil Chief Legal Officer 2021-06-02 Sale −2,387 $22.31 $53,257 131,688 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2021-06-01 Option exercise · Restricted Stock Units −33,189 0 D
Open-market sales · 45,119 sh · avg $22.10 · $996,963
Loading xslF345X03/doc4.xml…